Health Care: Drugs

ARIAD Pharmaceuticals Inc (ARIA: NASDAQ)

$12.95 0.19 | 1.49%
12/08/16 - 03:26 PM ET
Company Profile
Price and Volume
Recent Price 12.76
52 Week High 14.42
52 Week Low 4.37
Avg. Daily Vol. (Mil) 7.82
Beta (3 year) 3.23
Share Related Items
Mkt Cap (Mil) 2,478.00
Shares Out (Mil) 194.20
Float (Mil) 157.76
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 3.10
Current Ratio 3.20
LT Debt/ Equity 0.00
Total Debt / Equity n.a.
Valuation Ratios
Price Earnings n.a.
Price/Sales 13.31
Price/Book 0.00
Price/Cash Flow -152.00
Per Share Data
Earnings -0.18
Sales 0.96
Book Value 0.00
Cash Flow -0.08
Business Summary
ARIAD Pharmaceuticals Inc is an oncology company. The Company is engaged in transforming the lives of cancer patients with breakthrough medicines. It commercializes & develops products and product candidates including Iclusig, Brigatinib, and AP32788.
General Information
26 Landsdowne Street
Cambridge, MA 02139-4234
Industry : Drugs
Sector: Health Care
Employees: 459
CEO: Mr. Paris Panayiotopoulo
Short Interest
Current Month (Mil) 35.92
Previous Month (Mil) 36.60
Short Interest Ratio (Days) 3.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -4.70
Return on Investments -6.60
Gross Margin 98.30
EBIT Margin -11.50
Profit Margin -17.00

Portfolios with ARIA

Latest ARIA Headlines from TheStreet

More Financial News for ARIA

Press Releases for ARIA

See All Press Releases

Partner Headlines for ARIA

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter